Meconium testing detected prenatal cannabis and alcohol exposure that maternal self-reports missed, though sample sizes for positive cannabis results were small.
Read this if you are interested in how prenatal substance exposure is detected and how self-reports compare to biological testing.
Maternal self-reports and meconium testing agreed poorly for cannabis (Kappa = 0.30) and alcohol (Kappa = 0.13)
What the researchers found
This study compared what mothers reported about their substance use during pregnancy with what objective testing of their newborns' meconium (first stool) actually revealed.
For tobacco, meconium cotinine testing agreed well with maternal self-reports (Kappa = 0.79), and meconium testing actually predicted neonatal consequences of tobacco exposure better than self-reports alone.
For cannabis and alcohol, the story was different. Agreement between self-reports and meconium testing was low for both alcohol (Kappa = 0.13) and cannabis (Kappa = 0.30). Notably, the highest levels of alcohol metabolites in meconium were found in babies whose mothers denied drinking, suggesting significant underreporting of prenatal alcohol exposure.
Among 645 meconium samples collected from 724 mothers across all maternity units in Rouen, France, over two 5-week periods, polyconsumption (using multiple substances) was actually less common than expected based on meconium testing. An interesting finding in dizygotic twins showed that fetal exposure to substances can differ substantially even between twins sharing the same pregnancy.
Why it matters
Prenatal substance exposure has significant effects on neonatal health and child development. If mothers underreport cannabis and alcohol use during pregnancy, clinicians relying solely on self-reports will miss exposures. Meconium testing provides an objective alternative that captures third-trimester exposure.
The numbers in context
724 mothers, 645 meconium samples. Tobacco agreement: Kappa = 0.79. Alcohol agreement: Kappa = 0.13. Cannabis agreement: Kappa = 0.30. Total cannabinoid-positive meconium samples were small in number.
How the study worked
Cross-sectional study of 724 mothers and 645 meconium samples collected within 72 hours of delivery across all maternities in Rouen, Normandy. Maternal self-reports used the Addiction Severity Index (5th edition). Meconium was tested for cotinine (tobacco), ethyl-glucuronide (alcohol), and cannabinoid metabolites.
What this study cannot tell us
The number of cannabis-positive and alcohol-positive meconium samples was small, limiting statistical precision for these substances. Meconium reflects only third-trimester exposure and may miss earlier pregnancy use. Cultural factors in France may affect reporting patterns differently than in other countries.
How to read the evidence
Well-designed cross-sectional study with objective biomarker validation across all maternities in a defined region. Moderate because cannabis-positive sample sizes were small.
When this study was published
Published in 2017, with data from August 2010 and August 2011.
The bigger picture
The discrepancy between self-reported and objectively measured prenatal substance exposure has implications for both clinical care and research. Studies relying on maternal self-reports may systematically underestimate prenatal cannabis and alcohol exposure rates, leading to underestimation of associated health effects.
Questions still open
- Should routine meconium screening be implemented in clinical practice? Would non-judgmental screening environments improve maternal self-reporting accuracy? How does first-trimester cannabis exposure (missed by meconium) compare in neonatal effects to third-trimester exposure?
Common questions
Do mothers accurately report cannabis use during pregnancy?
What is meconium testing?
Read the original research
Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples of newborns compared to maternal self-reports.
Journal of psychiatric research, 90, 86-93
Citation
Lamy, Sandrine; Hennart, Benjamin; Houivet, Estelle; Dulaurent, Sylvain; Delavenne, Heloise; Benichou, Jacques; Allorge, Delphine; Marret, Stéphane; Thibaut, Florence. (2017). Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples of newborns compared to maternal self-reports.. Journal of psychiatric research, 90, 86-93. https://doi.org/10.1016/j.jpsychires.2017.02.012
Explore the wider topic
- How to Talk to Your Teenager About Weed (Without Losing Them)
- My Kid's Friends Smoke Weed: A Parent's Guide
- I Smoke Weed But Don't Want My Kids To: Navigating the Hypocrisy
- Quitting Weed as a Parent: Why It Is the Hardest and Most Important Quit
- Quitting Weed as a Teen or Young Adult
- My Kid Is Smoking Weed: A Parent's Guide